NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance (LRA) announced the first clinical trials to be conducted through the new Lupus Clinical Investigators Network (LuCIN). The LRA organized, manages and funds LuCIN to accelerate thef development of new lupus therapies. Comprising50+ top academic research centers throughout North America, LuCIN provides a framework to quickly and cost-effectively test potential new therapies, as well as methods to diagnose and monitor response to treatment.

The full press release is available on the Lupus Therapeutics website.

Read full Press Release